lobbying_activities: 3358102

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3358102	4b6934c5-f2bf-4951-a414-26175b5e693f	Q1	BUCHANAN INGERSOLL & ROONEY PC	55291	GENERIC ANIMAL DRUG ALLIANCE	2025	first_quarter	ANI	Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R. 1418, the Animal Drug User Fee Amendments of 2023, all provisions	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE			0	0	2025-04-21T13:44:52-04:00